Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Hollema

Showing results (81-90 of 131) with videos related to

Pageof 14
Sort By:
Epigenetics|September 29, 2012
Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasiaÁgnes Lendvai, Frank Johannes, Christina Grimm, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2017
Estrogen receptor α wields treatment-specific enhancers between morphologically similar endometrial tumorsMarjolein Droog, Ekaterina Nevedomskaya, Gwen M Dackus, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 3, 2012
Less gastrointestinal toxicity after adjuvant radiotherapy on a small pelvic field compared to a standard pelvic field in patients with endometrial carcinomaRenske A de Jong, Elisabeth Pras, H Marike Boezen, et al.
Oncotarget|May 3, 2018
Proteomic alterations in early stage cervical cancerCoşkun Güzel, Natalia I Govorukhina, G Bea A Wisman, et al.
International Journal of Cancer|September 4, 2009
The prognostic role of classical and nonclassical MHC class I expression in endometrial cancerClaudia B M Bijen, Enja J Bantema-Joppe, Renske A de Jong, et al.
Human Mutation|September 9, 2014
High frequency of RPL22 mutations in microsatellite-unstable colorectal and endometrial tumorsAna M Ferreira, Iina Tuominen, Krista van Dijk-Bos, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patientsJan J Koornstra, Fleur E M Rijcken, Corina N A M Oldenhuis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2006
Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patientsCaroline M van Geelen, Jantine L Westra, Elisabeth G de Vries, et al.
The Journal of Pathology|June 13, 2009
Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patientsAna M Ferreira, Helga Westers, Sónia Sousa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 13, 2011
Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodiesAnton G T Terwisscha van Scheltinga, Gooitzen M van Dam, Wouter B Nagengast, et al.
Pageof 14

Showing results (81-90 of 131) with videos related to

Sort By:
Pageof 14
Epigenetics|September 29, 2012
Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasiaÁgnes Lendvai, Frank Johannes, Christina Grimm, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2017
Estrogen receptor α wields treatment-specific enhancers between morphologically similar endometrial tumorsMarjolein Droog, Ekaterina Nevedomskaya, Gwen M Dackus, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 3, 2012
Less gastrointestinal toxicity after adjuvant radiotherapy on a small pelvic field compared to a standard pelvic field in patients with endometrial carcinomaRenske A de Jong, Elisabeth Pras, H Marike Boezen, et al.
Oncotarget|May 3, 2018
Proteomic alterations in early stage cervical cancerCoşkun Güzel, Natalia I Govorukhina, G Bea A Wisman, et al.
International Journal of Cancer|September 4, 2009
The prognostic role of classical and nonclassical MHC class I expression in endometrial cancerClaudia B M Bijen, Enja J Bantema-Joppe, Renske A de Jong, et al.
Human Mutation|September 9, 2014
High frequency of RPL22 mutations in microsatellite-unstable colorectal and endometrial tumorsAna M Ferreira, Iina Tuominen, Krista van Dijk-Bos, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patientsJan J Koornstra, Fleur E M Rijcken, Corina N A M Oldenhuis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2006
Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patientsCaroline M van Geelen, Jantine L Westra, Elisabeth G de Vries, et al.
The Journal of Pathology|June 13, 2009
Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patientsAna M Ferreira, Helga Westers, Sónia Sousa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 13, 2011
Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodiesAnton G T Terwisscha van Scheltinga, Gooitzen M van Dam, Wouter B Nagengast, et al.
Pageof 14